Thunder Bay Regional Health Research Institute
11
4
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
36.4%
4 terminated/withdrawn out of 11 trials
33.3%
-53.2% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Greenlight Vaporization vs Xpeeda Vaporesection
Role: lead
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
Role: lead
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Role: lead
HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease
Role: lead
Mini-PNCL vs fURS in Management of Nephrolithiasis
Role: lead
Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)
Role: lead
Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) vs 26 F Sheath HoLEP for BPH: RCT
Role: lead
Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones
Role: lead
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
Role: lead
Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury
Role: lead
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
Role: lead
All 11 trials loaded